Join Business Exchange
to access the mostrelevant content for you,
filtered by like-mindedbusiness professionals.
Pfizer (NYSE: PFE The company previously announced last November that axitinib had passed its phase 3 trial testing it against Bayer and Onyx Pharmaceuticals' (Nasdaq: ONXX Axitinib extended progression-free survival of...
to access the most relevant content for you, filtered by like-minded business professionals.
About Business Exchange
Send us Feedback
©2013 Bloomberg L.P. All Rights Reserved.